Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

To differentiate in a crowded market, Atlas Bar conducted clinical tests to prove its product has a negligible effect on blood sugar. This scientific approach provides quantifiable proof of its health benefits—a 77% lower blood sugar response than white bread—shifting from typical marketing claims to evidence-based validation.

Related Insights

In the crowded "healthy" food market, simply listing clean ingredients is insufficient. Brands must educate consumers on their unique processes (e.g., stone-milling grains) to demonstrate superior nutritional value and build trust. Framing it as a founder's personal mission adds authenticity.

In crowded retail, packaging is the primary salesperson. Brands like RXBAR won by clearly stating value props (macros, simple ingredients) on the front. A new brand must do the same, highlighting key benefits like "slow burning energy" or "clean carbs" to capture attention instantly.

AG1 made a strategic shift from influencer-led marketing to a science-first approach. The company invested over $10 million in double-blind, placebo-controlled human trials and built campaigns around this scientific validation. This move aims to build deep credibility and differentiate the brand in a crowded, often unsubstantiated market.

For those transitioning from biopharma to food tech, the concept of 'efficacy' requires a major mindset shift. While drug efficacy is about clinical outcomes, food efficacy is defined by the consumer's sensory experience—including texture, mouthfeel, aftertaste, and packaging. This is a critical factor for product success.

To differentiate from competitors and build consumer trust, Olipop substantiates its health claims with empirical data. The company partners with Purdue University's labs to run in-vitro and human clinical trials that validate the product's positive effects on microbiome health and blood sugar stability.

Naming the brand "This Works" created a non-negotiable promise to consumers. This forced the company to build its entire marketing and R&D strategy around tangible evidence, including user studies, clinical trials, and neuroscience research, to continuously earn brand trust through "proof-pointing".

The founder, a former elite athlete, argues that 95% of 'functional' products lack true efficacy. He believes brands delivering real, measurable health benefits will win long-term as consumer education grows, making genuine functionality the ultimate competitive advantage over marketing-driven noise.

Investing in clinical studies is not just for product validation; it's a powerful marketing strategy. It allows you to make scientifically-backed claims in ads that competitors cannot legally replicate, creating a significant and sustainable competitive advantage.

To demonstrate his conviction in Atlas Bar's quality, the founder undertook an extreme physical challenge: running 100 miles in six days, fueled only by his product and water. This act of "dogfooding" served as a powerful, authentic marketing statement, showing he personally stands behind the product's efficacy under demanding conditions.

To build credibility in the modern healthcare landscape, Elix invests in formal, IRB-approved clinical studies for its traditional formulas. This strategy provides scientific validation, allowing them to operate as a credible resource alongside Western medicine, not in opposition to it.

Atlas Bar Uses Clinical Trials To Validate Nutritional Claims, a Rarity in CPG | RiffOn